Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma Journal Article


Authors: Caruso, J. P.; Cohen-Inbar, O.; Bilsky, M. H.; Gerszten, P. C.; Sheehan, J. P.
Article Title: Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma
Abstract: The management of metastatic spinal melanoma involves maximizing local control, preventing recurrence, and minimizing treatment-associated toxicity and spinal cord damage. Additionally, therapeutic measures should promote mechanical stability, facilitate rehabilitation, and promote quality of life. These objectives prove difficult to achieve given melanoma's elusive nature, radioresistant and chemoresistant histology, vascular character, and tendency for rapid and early metastasis. Different therapeutic modalities exist for metastatic spinal melanoma treatment, including resection (definitive, debulking, or stabilization procedures), stereotactic radiosurgery, and immunotherapeutic techniques, but no single treatment modality has proven fully effective. The authors present a conceptual overview and critique of these techniques, assessing their effectiveness, separately and combined, in the treatment of metastatic spinal melanoma. They provide an up-to-date guide for multidisciplinary treatment strategies. Protocols that incorporate specific, goal-defined surgery, immunotherapy, and stereotactic radiosurgery would be beneficial in efforts to maximize local control and minimize toxicity.
Keywords: review; radiotherapy; immunotherapy; surgery; stereotactic radiosurgery; separation; interferon-alpha; brain metastases; cancer-immunotherapy; tumor-infiltrating lymphocytes; ctla-4 blockade; single-institution; high-risk melanoma; body; dose interleukin-2; separation surgery; metastatic spinal melanoma
Journal Title: Neurosurgical Focus
Volume: 38
Issue: 3
ISSN: 1092-0684
Publisher: American Association of Neurological Surgeons  
Date Published: 2015-03-01
Start Page: E6
Language: English
ACCESSION: WOS:000350422600002
DOI: 10.3171/2014.11.focus14716
PROVIDER: wos
PUBMED: 25727228
Notes: Article -- E6 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark H Bilsky
    319 Bilsky